DCF — SACRED HEART MED CTR - UNIVERSITY
Enterprise Value: $-93.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-93.6M
Enterprise Value
$-31.3M
PV of Cash Flows
$-62.3M
PV of Terminal Value
$-100.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $109.0M | $-4.9M | -4.0% | $-9.5M | $-8.7M |
| Year 2 | $112.2M | $-3.9M | -3.0% | $-8.7M | $-7.2M |
| Year 3 | $115.6M | $-2.9M | -2.0% | $-7.8M | $-5.8M |
| Year 4 | $119.1M | $-2.4M | -2.0% | $-7.4M | $-5.1M |
| Year 5 | $122.6M | $-2.1M | -2.0% | $-7.3M | $-4.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-93.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$105.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999998109342116
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5